From the 1Endocrinology and Metabolism, University of California, San Diego; 2The North American Menopause Society, Consultant Cleveland Clinic Center for Specialized Women’s Health, and Department of Reproductive Biology, Case Western Reserve University School of Medicine; 3The Michael and Lee Bell Professor of Women’s Health, Harvard Medical School, and Connors Center for Women’s Health and Gender Biology, Brigham and Women’s Hospital; 4Department of Obstetrics and Gynecology, Columbia University; 5Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, Director Program for Polycystic Ovarian Syndrome, Director Program for Reproductive Aging and Bone Health; 6American Society for Reproductive Medicine; and 7Department of Medicine Harvard Medical School.
Received May 30, 2012; revised and accepted May 30, 2012.
This statement was prepared by The North American Menopause Society, the American Society for Reproductive Medicine and The Endocrine Society. It is being simultaneously published in the journals Fertility and Sterility, the Journal of Clinical Endocrinology and Metabolism, and Menopause.
Financial Disclosure/Conflicts of Interest: Dr. Gass, Dr Hall, Dr. Lobo, Dr. Manson—No significant financial relationships. Dr. Pal—travel support from EHSRE. Dr. Rebar—Consultant/advisory board KEEPS Study of Hormone Therapy; editorial board Journal Watch Women’s Health. Dr. Stuenkel—Consultant Novogyne, Pharmavite.